Genetic analysis of HLA- and HPA-typing in idiopathic (autoimmune) thrombocytopenic purpura patients treated with cepharanthin.

Nomura, S

Genetic analysis of HLA- and HPA-typing in idiopathic (autoimmune) thrombocytopenic purpura patients treated with cepharanthin. [electronic resource] - Autoimmunity 1999 - 99-105 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0891-6934

10.3109/08916939908994767 doi


Adult
Aged
Alkaloids--pharmacology
Anti-Inflammatory Agents--therapeutic use
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Antigens, Human Platelet--analysis
Autoantigens--genetics
Autoimmune Diseases--drug therapy
Benzylisoquinolines
Blood Platelets--immunology
Combined Modality Therapy
Drug Resistance--genetics
Endocytosis--drug effects
Female
Genetic Predisposition to Disease
Genotype
HLA Antigens--analysis
HLA-DQ Antigens--analysis
HLA-DQ beta-Chains
HLA-DR Antigens--analysis
HLA-DRB1 Chains
Humans
Male
Middle Aged
Polymerase Chain Reaction
Polymorphism, Restriction Fragment Length
Polymorphism, Single-Stranded Conformational
Prednisolone--therapeutic use
Purpura, Thrombocytopenic, Idiopathic--drug therapy
Splenectomy
Treatment Outcome